Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
Diagnostics (Basel, Switzerland)|November 26, 2022
Added Value of Ultrasound-Based Multimodal Imaging to Diagnose Hepatic Sclerosed Hemangioma before Biopsy and ResectionFeiqian Wang, Kazushi Numata, Hiromi Nihonmatsu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 8, 2014
Field practice study of half-dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysisManabu Morimoto, Kazushi Numata, Masaaki Kondo, et al.
Internal Medicine (Tokyo, Japan)|March 1, 2021
Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the PancreasHaruo Miwa, Kazuya Sugimori, Tomohiro Ishii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 5, 2023
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II studyNaoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, et al.
International Journal of Computer Assisted Radiology and Surgery|July 19, 2017
A new device for fiducial registration of image-guided navigation system for liver RFANobutaka Doba, Hiroyuki Fukuda, Kazushi Numata, et al.
Quantitative Imaging in Medicine and Surgery|June 3, 2021
Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinomaFeiqian Wang, Kazushi Numata, Masahiro Okada, et al.
Abdominal Imaging|June 4, 2013
High-intensity focused ultrasound ablation assisted using color Doppler imaging for the treatment of hepatocellular carcinomasHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Journal of Gastroenterology|January 4, 2021
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter studyMasatoshi Kudo, Kaoru Tsuchiya, Naoya Kato, et al.
Journal of Surgical Oncology|April 5, 2014
Impact of overexpression of Sushi repeat-containing protein X-linked 2 gene on outcomes of gastric cancerTakanobu Yamada, Takashi Oshima, Kazue Yoshihara, et al.
Liver Cancer|July 31, 2026
Real-World Evidence from a Nationwide Prospective Study of the Efficacy/Safety of Systemic Therapy for Unresectable Hepatocellular Carcinoma: First 1,000 Patients of the PRISM StudyMasafumi Ikeda, Shinji Itoh, Daisuke Onozuka, et al.
Pageof 20